2. Infection

Infection

Infection

Related Products

PDF 70.44 MB

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N14593
    Roridin D 14682-29-2 98%
    Roridin D is a natural compound foun in Myrothecium roridum S-1135 (NRRL 3005).
    Roridin D
  • HY-N14595
    Resorcinomycin B 100234-69-3 98%
    Resorcinomycin B is an antibiotic found in Streptoverticillum roseoverticillatum.
    Resorcinomycin B
  • HY-N14599
    Resorthiomycin 126651-92-1 98%
    Resorthiomycin is a an antitumor antibiotic that can inhibit L5178Y of leukemia cells in vitro.
    Resorthiomycin
  • HY-N14603
    Chandrananimycin A 664355-12-8 98%
    Chandrananimycin A has anti-mucor activity, as well as anti-tumor cell activity such as CCL HT29, MFXF 529L, MACL McF-7.
    Chandrananimycin A
  • HY-N14604
    Chandrananimycin B 664355-13-9 98%
    Chandrananimycin B has anti-mucor activity, as well as anti-tumor cell activity such as CCL HT29, MFXF 529L, MACL McF-7.
    Chandrananimycin B
  • HY-N14606
    Pacidamycin 3 121280-49-7 98%
    Pacidamycin 32 has inhibitory effect on Pseudomonas aeruginosa. Pacidamycin 3 also has effect on a few strains of bacteria such as Suppurative staphylococcus and Escherichia coli.
    Pacidamycin 3
  • HY-N14607
    Pacidamycin 5 122855-43-0 98%
    Pacidamycin 5 has inhibitory effect on Pseudomonas aeruginosa. Pacidamycin 5 also has effect on a few strains of bacteria such as Suppurative staphylococcus and Escherichia coli.
    Pacidamycin 5
  • HY-N14610
    Grahamimycin B 883434-90-0 98%
    Grahamimycin B has weak activity against Gram-positive bacteria, negative bacteria, cyanobacteria and green algae.
    Grahamimycin B
  • HY-N14611
    Pyrazomycin Ⅱ 41855-21-4 98%
    Pyrazomycin II (Pyrazomycin B) is an antibiotic. Pyrazomycin is a competitive inhibitor of pyrimidine nucleoside metabolism.
    Pyrazomycin Ⅱ
  • HY-N14612
    Griseochelin 91920-88-6 98%
    Griseochelin has anti-Gram-negative bacterial activity, and has inhibitory effect on coccidioides.
    Griseochelin
  • HY-N14613
    Rhodomycin B 1404-52-0 98%
    Rhodomycin B has the activity of anti-Gram-positive bacteria and weak effect on anti-Gram-negative bacteria and fungi.
    Rhodomycin B
  • HY-N14615
    Pyrisulfoxin A 187337-07-1 98%
    Pyrisulfoxin A is an antibiotic found in Streptomyces callfornicus BS-75.
    Pyrisulfoxin A
  • HY-N14616
    Reumycin 5016-18-2 98%
    Reumycin is a 7-azapteridine antibiotic. Reumycin is toxic to Airy carcinoma, sarcoma-180, sarcoma-37, lymphosarcoma and other tumor cells.
    Reumycin
  • HY-N14622
    Fudecalone 162341-22-2 98%
    Fudecalone is found in the strain of Penicillum sp. FO-2030. Fudecalone completely inhibits Eimeria Tenella, a coccidius resistant to Monesin (HY-N4302).
    Fudecalone
  • HY-N14623
    Paulomycin B 81988-76-3 98%
    Paulomycin B has anti-Gram-positive bacteria effect, and it has inhibitory effect on Staphylococcus aureus resistant to penicillin, Streptomycin, Neomycin and Macrolide antibiotics.
    Paulomycin B
  • HY-N14626
    Pelagiomicin C 173485-82-0 98%
    Pelagiomicin C has the activity against Gram-positive bacteria and Gram-negative bacteria.
    Pelagiomicin C
  • HY-N14635
    Paeciloquinone A 162797-33-3 98%
    Paeciloquinone A can inhibit EGFR protein tyrosine kinase. Paeciloquinone A inhibits the V-abl protein tyrosine kinase with an IC50 of 0.59 μM.
    Paeciloquinone A
  • HY-N14636
    Paeciloquinone B 162797-34-4 98%
    Paeciloquinone B can inhibit the EGFR protein tyrosine kinase.
    Paeciloquinone B
  • HY-N14637
    Paeciloquinone C 92439-42-4 98%
    Paeciloquinone C can inhibit the EGFR protein tyrosine kinase. Paeciloquinone C inhibits the V-abl protein tyrosine Kinase with an IC50 of 0.56 μM.
    Paeciloquinone C
  • HY-N14638
    Paeciloquinone D 162797-35-5 98%
    Paeciloquinone D can inhibit the EGFR protein tyrosine kinase.
    Paeciloquinone D
Cat. No. Product Name / Synonyms Application Reactivity